dibenzylchlorethamine has been researched along with Experimental Mammary Neoplasms in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cory, RN | 1 |
| Rouot, B | 1 |
| Guillon, G | 1 |
| Sladeczek, F | 1 |
| Balestre, MN | 1 |
| Bockaert, J | 1 |
1 other study available for dibenzylchlorethamine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The 5-hydroxytryptamine (5-HT2) receptor stimulates inositol phosphate formation in intact and broken WRK1 cells: determination of occupancy-response relationships for 5-HT agonists.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bufotenin; Cell Line; Dibenzyl | 1987 |